New Outcomes Data Demonstrating Prolonged Survival for Inoperable Pancreatic Cancer Patients
UF startup ViewRay, Inc., a leading medical technology company that provides groundbreaking MRI-guided radiation therapy, announced that the results of a multi-center study of 148 inoperable pancreatic cancer patients treated with MRIdian SMART (MR-guided stereotactic adaptive radiation therapy) were presented as part of the Annual Meeting of the American Society for Radiation Oncology (ASTRO), the world's largest radiation oncology society.
ViewRay Announces 510(k) Pending Status of the Newest Generation of MRIdian Innovations
UF startup ViewRay, Inc., a leading medical technology company that provides groundbreaking MRI-guided radiation therapy, announced that the company has received acceptance from the FDA on their recent submission for new MRIdian features focused on enhancing on-table adaptive workflow efficiency and expanding clinical utility.
Amsterdam University Medical Centers Treats 1,000th Patient With MRIdian SMART MRI-Guided Radiation Therapy
UF startup ViewRay, Inc., a leading medical technology company that provides groundbreaking MRI-guided radiation therapy, announced that the clinical team at Amsterdam... Read More
ASTRO 2020 to Feature Latest MRIdian Clinical Experience Highlighting Outcomes in Tough to Treat Cancer
UF startup ViewRay Inc., a leading medical technology company that provides groundbreaking MRI-guided radiation therapy, announced that the company’s MRIdian® Linac MRI-guided... Read More
Providence Portland Medical Center Begins Patient Treatments With ViewRay’s MRIdian Linac
UF startup ViewRay, Inc. announced that Providence Portland Medical Center in Portland, Oregon has begun patient treatments with the MRIdian® MR-Guided Therapy System, a cutting-edge... Read More
New Hope for Patients Battling Inoperable Cancer
Doctors at Sparrow’s Herbert-Herman Cancer Center in Lansing, Michigan have a new tool to deliver radiation. It’s one of only 12 in the country.... Read More
ASTRO 2019 to Feature Clinical Experience and Patient Outcomes With Viewray MRIdian
UF startup ViewRay, Inc., a leading medical technology company that provides groundbreaking MRI-guided radiation therapy, announced that the company’s MRIdian and MRIdian... Read More
MRIdian System Limits Early Toxicity for Prostate Cancer Without Implanted Markers
UF startup ViewRay Inc., a leading medical technology company that provides groundbreaking MRI-guided radiation therapy, announced the acceptance of publication by the... Read More
FDA Clears Advancements for Viewray MRIdian Radiation Therapy System
UF startup ViewRay Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market new soft tissue visualization capabilities... Read More
ViewRay to Supply UK’s GenesisCare With Country’s First MRIdian Systems (DOTmed)
UF startup ViewRay Inc. is set to deliver the first of Great Britain’s MRIdian MR-guided radiotherapy systems as part of a new... Read More
